Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (33,442) $ (19,911)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 20 21
Common stock issued to acquire in-process research and development 1,360  
Stock-based compensation 2,005 1,098
Changes in operating assets and liabilities:    
Prepaid expenses and other (3,662) (508)
Accounts payable (1,301) (285)
Lease liabilities and ROU asset, net 8 2
Accrued expenses and other current liabilities 360 (417)
Net cash used in operating activities (34,652) (20,000)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (4,030) (12)
Net cash used in investing activities (4,030) (12)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from exercise of warrants 9,896 70
Proceeds from ESPP 2 31
Proceeds, net of $711 and $0 expenses, from sale of preferred stock 4,602  
Proceeds, net of $3,740 and $485 expenses, from sale of common stock and warrants 68,746 4,904
Net cash provided by financing activities 83,246 5,005
Effect of currency rate change on cash (16) (3)
Net increase (decrease) in cash, cash equivalents and restricted cash 44,548 (15,010)
Cash, cash equivalents and restricted cash beginning of the period 11,349 25,134
Cash, cash equivalents and restricted cash end of period 55,897 $ 10,124
Supplemental disclosures of cash flow information:    
Warrants deemed dividend 451  
Series B Convertible preferred stock and deemed dividend $ 1,260